Sarcoidosis is a multisystem disease involving most frequently the lung, the eyes, the lymph
nodes and the skin. Skin lesions may be disfiguring and impair the quality of life.
Thalidomide is a multi-target drug that has been shown to be of benefit in skin sarcoidosis
in case reports. The objective is to assess the efficacy and tolerance of thalidomide in skin
sarcoidosis.